BT and Accelrys Unlock Value in Big Data - - BioPharm International

ADVERTISEMENT

BT and Accelrys Unlock Value in Big Data


British Telecommunications (BT) and Accelrys are collaborating to provide solutions for analyzing massive datasets using BT for Life Sciences Cloud Compute Platform combined with Accelrys Enterprise Platform and Accelrys Pipeline Pilot software, the companies announced in a press release.  The tools can be used to mine information on healthcare topics from very large datasets.

BT has collated publically available health system and social care information into a research repository intended for use by the life sciences and health care industries as well as academia, initially hosted in the United States and UK, but available for global access. Such data can provide valuable insight into a number of healthcare topics, such as disease prevalence, impact of ethnic mix and adverse drug reactions. However, the information is often contained in very large datasets and may be unstructured in nature. The datasets can be analyzed using the BT and Accelrys tools.

“The generation of ever-increasing amounts of health data is both a blessing and a curse, as they are data-rich, but often information-poor,” said Leif Pedersen, senior vice president of marketing, product management and corporate development at Accelrys, in the press release. “Working with BT, we’ve shown that we can deliver meaningful and valuable insights from these huge datasets.”

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines

Click here